Baird Maintains an 'Outperform' on InterMune (ITMN); Successful Pricing/Reimbursement for Esbriet

September 11, 2012 9:49 AM EDT Send to a Friend
Baird maintains an 'Outperform' on InterMune Inc. (NASDAQ: ITMN) price target of $20.00.

Analyst, Thomas J. Russo, said, "Remain ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login